Advertisement
Canada markets closed
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7322
    -0.0001 (-0.01%)
     
  • CRUDE OIL

    83.88
    +0.31 (+0.37%)
     
  • Bitcoin CAD

    87,402.64
    -728.16 (-0.83%)
     
  • CMC Crypto 200

    1,388.71
    +6.14 (+0.44%)
     
  • GOLD FUTURES

    2,340.20
    -2.30 (-0.10%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,755.50
    +188.00 (+1.07%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,606.53
    -21.95 (-0.06%)
     
  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Richest CEOs reportedly earn 235 times average salary

By the time you read this, the typical CEO of a major Canadian company will already have earned more this year than you will for all of 2013.

That's the conclusion of a report from left-leaning think-tank the Canadian Centre for Policy Alternatives this week.

The report, with the cheeky title "Overcompensating," found the average salary among Canada's 100 highest paid chief executive officers was $7.7 million in 2011.

Average compensation for Canada's 50 richest CEOs is more than 235 times the salary of the average Canadian salaried worker, a ratio that has expanded rapidly in recent years. In 1995, the group notes, that ratio sat at 85-1.

ADVERTISEMENT

"By 1:18 p.m. on Jan. 2, the first official working day of the year," the group said in a press release, "Canada’s top 100 CEOs will have already pocketed $45,448. It takes the average Canadian an entire year of full-time work to earn that."

Although he has since been given a generous package to relinquish control of the company, Frank Stronach was Canada's highest-paid CEO in 2011, taking in almost $41 million in compensation to head up the auto-parts conglomerate Magna, which he founded.

No. 2 on the list was a little less well known — Michael Pearson of generic drug manufacturer Valeant. He pocketed more than $36 million, the CCPA says.